$CODX Cashflow Statement | Understand Stock

$CODX

$0.47 -$0.08 (14.32%) Close

$CODX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss, as reported
Adjustments to reconcile net loss to cash used in operating activities:
Goodwill impairment charges
Depreciation and amortization
Impairment charges
Stock-based compensation expense
Common stock issued for financial advisory services
Change in fair value of acquisition contingencies
Non-cash lease expense
Realized gain on investments
Loss from equity method investment
(Gain) loss on disposition of assets
Deferred income taxes
Provision for (recoveries of) credit losses
Recoveries of credit losses
Inventory obsolescence expense (recovery)
Changes in assets and liabilities:
Accounts receivable
Prepaid expenses and other assets
Inventory
Deferred revenue
Income taxes payable
Accounts payable, accrued expenses and other liabilities

Net cash used in operating activities
Cash flows from investing activities
Purchases of property and equipment
Proceeds from maturities of marketable investment securities
Purchases of marketable securities
Investment in joint venture
Business combinations, net of cash acquired
Investment in joint ventures
Net cash provided by investing activities

Cash flows from financing activities
Proceeds from exercise of options and warrants
Repurchases of common stock
Proceeds from exercise of options
Issuance of common stock related to at-the-market offering, net of offering costs
Issuance of common stock related to registered direct offering, net of offering costs
Net cash provided by financing activities

Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of cash flow information
Cash received for income taxes
Supplemental disclosure of non-cash investing and financing transactions
Inventory moved to property, plant and equipment
Right-of-use assets obtained in exchange for new operating lease liabilities
Business acquisition measurement period adjustments
Fair value of common stock issued as consideration for business acquisitions
Fair value of contingent common stock issued as consideration for business acquisitions
Receivable from issuance of common stock, collected in 2025

Comments